04/06/2026
Recent media coverage on hormonal contraception and meningioma may raise questions for women using or considering contraceptive methods.
For most women, effective contraception plays an important role in supporting their health, wellbeing and reproductive choices and the overall risk of developing a meningioma remains very low.
Understanding the evidence can help support informed contraceptive choices.
Read our summary on hormonal contraception and brain tumour risk: https://cosrh.org/Public/News/Articles/hormonal-contraception-and-brain-tumour-risk.aspx
For healthcare professionals, a separate clinical statement is also available with more detailed guidance for clinicians: https://cosrh.org/Public/Documents/cosrh-statement-meningioma-and-progestogens.aspx